...said it closed a series B round with $60 million. Investors included Forbion Capital Partners, NGN Capital...

...bringing the total raised in the round to $44.6 million. Existing investors Forbion Capital Partners; NGN Capital...

...Also new to the syndicate were Tiger Partners; CD Ventures; and Monashee Capital. Existing investors NGN Capital...

...agent: Leerink Partners Investors: Qiagen N.V. ; Arcus Ventures; Tiger Partners; CD Ventures; Monashee Capital; NGN Capital...

...New investors Tiger Partners; CD Ventures; and Monashee Capital also participated, along with existing investors NGN Capital...

...the 2008 deal with Bayer, ACT raised $12 million in a series A round from NGN Capital...
...University collaborators: None Corporate partners: None Number of employees: 6 Funds raised: $18 million Investors: NGN Capital...

...than glioblastoma. Exosome raised $20 million last month in a series A round co-led by NGN Capital...
...San Diego Corporate partners: Not disclosed Number of employees: 15 Funds raised: $22 million Investors: NGN Capital...

...Business: Autoimmune, Cancer, Endocrine Date completed: 5/27/10 Type: Venture financing Raised:€33 million ($41.2 million) Investors: NGN Capital...

...raised EUR 33 million ($41.2 million) in a series D round led by new investor NGN Capital...
...diabetic nephropathy and NOX-A12 for autologous hematopoietic stem cell transplantation in patients with hematological malignancies. NGN Capital's...

...Diagnostics Inc. , New York, N.Y. Business: Diagnostic Appointed: Peter Johann, managing general partner at NGN Capital...
...Geert-Jan Mulder, general partner at Forbion Capital Partners; and Georg Nebgen, managing general partner at NGN Capital WIR...